Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

BACKGROUND: Following the release of the 2002 report of the Women’s Health Initiative (WHI) trial of estrogen plus progestin, the use of menopausal hormone therapy in the United States decreased substantially. Subsequently, the incidence of breast cancer also dropped, suggesting a cause-and-effect r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chlebowski, Rowan T., Kuller, Lewis H., Prentice, Ross L., Stefanick, Marcia L., Manson, JoAnn E., Gass, Margery, Aragaki, Aaron K., Ockene, Judith K., Lane, Dorothy S., Sarto, Gloria E., Rajkovic, Aleksandar, Schenken, Robert, Hendrix, Susan L., Ravdin, Peter M., Rohan, Thomas E., Yasmeen, Shagufta, Anderson, Garnet
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3963492/
https://ncbi.nlm.nih.gov/pubmed/19196674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0807684
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items